Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jan 27, 2023; 15(1): 32-48
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.32
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.32
Figure 2 Comparison of overall survival and progression-free survival before and after propensity score matching in stage II gastric cancer patients.
A: Comparison of overall survival between the two groups based on chemotherapy cycles before propensity score matching (PSM); B: Comparison of progression-free survival between the two groups based on chemotherapy cycles before PSM; C and D: Comparison of overall survival (C) and progression-free survival (D) between the two groups based on chemotherapy cycles after PSM.
- Citation: Li YF, Zhang WB, Gao YY. Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy. World J Gastrointest Surg 2023; 15(1): 32-48
- URL: https://www.wjgnet.com/1948-9366/full/v15/i1/32.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i1.32